Connect with us

Published

on

Sundar Pichai, CEO of Google
Anindito Mukherjee | Bloomberg | Getty Images

Several hundred Google employees have signed and circulated a manifesto opposing the company’s vaccine mandate, posing the latest challenge for leadership as it approaches key deadlines for returning workers to offices in person.

The Biden administration has ordered U.S. companies with 100 or more workers to ensure their employees are fully vaccinated or regularly tested for Covid-19 by Jan. 4. In response, Google has asked its more than 150,000 employees to upload their vaccination status to its internal systems by Dec. 3, whether they plan on coming into the office or not, according to internal documents viewed by CNBC. The company has also said that all employees who work directly or indirectly with government contracts must be vaccinated — even if they are working from home.

“Vaccines are key to our ability to enable a safe return to office for everyone and minimize the spread of Covid-19 in our communities, wrote Chris Rackow, Google VP of security, in an email sent near the end of October.

Rackow stated the company was already implementing requirements, so the changes from Biden’s executive order were “minimal.” His email gave a deadline of Nov. 12 for employees to request exemptions for reasons such as religious beliefs or medical conditions, and said that cases would be decided on a case-by-case basis.

The manifesto within Google, which has been signed by at least 600 Google employees, asks company leaders to retract the vaccine mandate and create a new one that is “inclusive of all Googlers,” arguing leadership’s decision will have outsized influence in corporate America. It also calls on employees to “oppose the mandate as a matter of principle” and tells employees to not let the policy alter their decision if they’ve already chosen not to receive the Covid-19 shot.

The manifesto comes as most of the Google workforce approaches a deadline to return to physical offices three days a week starting Jan. 10. The company’s notably outspoken employees have previously debated everything from government contracts to cafeteria food changes. 

A spokesperson for Google said the company stands behind its policy. “As we’ve stated to all our employees and the author of this document, our vaccination requirements are one of the most important ways we can keep our workforce safe and keep our services running. We firmly stand behind our vaccination policy.”

The mandate dilemma

Vaccination is a dilemma not only for Google, but for corporate America in general. The Covid-19 virus has contributed to 772,570 deaths in the U.S., according to Johns Hopkins data. Despite proven effectiveness in providing a high level of protection against hospitalization and death, the country is struggling to persuade millions of people to get their first dose, as more than 60 million Americans remain unvaccinated.

In July, CEO Sundar Pichai announced the company would require vaccinations for those returning to offices. In October, Pichai said that the San Francisco Bay Area offices, near its headquarters, are up to 30% filled while New York is seeing nearly half of its employees back. He added at that time that employees who don’t want to get vaccinated would be able to continue working remotely. 

The company has taken other steps to convince employees to get vaccinated as well. For instance, Joe Kava, vice president of data centers at Google, announced a $5,000 vaccination incentive spot bonus for U.S. data center employees, according to the manifesto.

In an email cited in the manifesto and viewed by CNBC, Google VP of global security Chris Rackow said that because of the company’s work with the federal government, which “today encompasses products and services spanning Ads, Cloud Maps, Workspace and more,” all employees working directly or indirectly with government contracts will require vaccinations — even if they are working from home. Frequent testing is “not a valid alternative,” he added.

The authors of the manifesto strongly disagree.

“I believe that Sundar’s Vaccine Mandate is deeply flawed,” the manifesto states, calling company leadership “coercive,” and “the antithesis of inclusion.” 

In a subhead titled “Respect the User,” the authors write that the mandate of “barring unvaccinated Googlers from the office publicly and possibly embarrassingly exposes a private choice as it would be difficult for the Googler not to reveal why they cannot return.”

The author also argues the mandate violates the company’s principles of inclusiveness.

“Such Googlers may never feel comfortable expressing their true sentiments about a company health policy and other, unrelated sensitive topics. This results in silenced perspective and exacerbates the internal ideological ‘echo chamber’ which folks both inside and outside of Google have observed for years.”

The manifesto also opposes Google having a record of employees’ vaccination status.

“I do not believe Google should be privy to the health and medical history of Googlers and the vaccination status is no exception.” Google has asked employees to upload their vaccination proof to Google’s “environmental health and safety” team even if they already uploaded it to One Medical, one of Google’s benefits providers, according to internal documentation.

The author then tries to argue the vaccine mandate may be the start of a slippery slope, paving the way for other intrusive measures — a common line of argument among people opposed to the mandates.

“It normalizes medical intervention compulsion not only for Covid-19 vaccination but for future vaccines and possibly even non-vaccine interventions by extension. It justifies the principle of division and unequal treatment of Googlers based on their personal beliefs and decisions. The implications are chilling. Due to its presence as an industry leader, Google’s mandate will influence companies around the world to consider these as acceptable tradeoffs.”

The group has sent these concerns in an open letter to Google’s chief health officer Karen DeSalvo, the document states.

In Google’s most recent all-hands meeting, called TGIF, some employees attempted to bring more attention to the vaccine question by getting fellow employees “downvote” other questions in an internal system called Dory, according to an internal email chain viewed by CNBC. The goal was to ensure their questions would gain enough votes to qualify for executives to address them.

Google’s health ambitions

The pushback against vaccine mandates poses a new challenge for Google’s leadership at a time when it is trying to target the healthcare industry among its growing business ambitions — particularly for its cloud unit. 

In August, Google disbanded its health unit as a formalized business unit for the health-care sector and Dr. David Feinberg, who spent the past two years leading the search giant’s health care unit, left the company. Nonetheless, Google Cloud CEO Thomas Kurian has routinely mentioned healthcare sector as a key focus area and DeSalvo, an ex-Obama administrator whom Google hired as its first health chief in 2019, told CNBC’s “Squawk Box” last month the tech giant is “still all in on health.”

The company has tried to capitalize on the broader fight against Covid in several ways. In the first half of 2021, the company spent nearly $30 million on at-home Covid tests for employees from Cue Health, which went public in September at a $3 billion valuation. Shortly after, the company announced a separate partnership with Google’s cloud unit to collect and analyze Covid-19 data with hopes of predicting future variants. Google also teamed up with Apple for an opt-in contract tracing software in hopes of tracking Covid-19.

Continue Reading

Technology

This startup helps plants talk to farmers, reducing pesticides and agricultural waste

Published

on

By

This startup helps plants talk to farmers, reducing pesticides and agricultural waste

Scientists creating 'talking' plants to reduce crop waste

What if plants could talk to farmers and tell them when they’re in distress? That would not only save the plants, but it could reduce the amount of agricultural waste that threatens the planet’s health.

Much of agriculture may look green, but the industry is one of the world’s biggest carbon offenders. It accounts for at least 10% of global greenhouse gas emissions. Agricultural waste adds to the problem.

Even with the use of pesticides, 40% of most food crops globally are lost to disease and pests. Now companies like SatAgro, Climate FieldView and a California-based startup called InnerPlant are working to reduce agricultural waste. InnerPlant helps crops communicate with their farmers by using genetic engineering.

InnerPlant’s technology uses fluorescents in the plants, so the leaves emit a signal when they are in distress. That signal is detectable from devices that can be attached to satellites, drones or tractors.

“As the plant is reacting to the stresses in your environment, like fungal pressure insects or nitrogen deficiency, it will start to signal and then we can help farmers understand what areas of the field need something and what areas are fine and don’t need additional chemicals,” said Shely Aronov, CEO of InnerPlant.

Farmers then know what to treat and don’t waste money on chemicals, which are up to 30% over-applied.

“We want to eliminate all the unnecessary applications of chemicals into our food system, into our soils and also the additional cost that comes to farmers that they don’t get any benefit from,” added Aronov.

This plant-by-plant technology is highly scalable and could be licensed to major seed companies. InnerPlant would earn royalty revenue, which makes it enticing to investors.

“If you can get this technology into every single corn seed or soybean seed across North America and South America, that is many hundred millions of acres, and you can think about a few dollars per acre from a revenue perspective. That all of a sudden ends up in a lot of revenue for this business,” said Tom Biegala, founding partner of Bison Ventures, an InnerPlant investor.

In addition to Bison Ventures, InnerPlant is backed by John Deere, MS&AD Ventures, UpWest VC and Bee Partners. It has $22.3 million in total funding.

InnerPlant is now working closely with small farmers and some of the nation’s largest agriculture producers. Some have paid to get early access to the technology, which will start with soybeans and then expand to other crops.

Continue Reading

Technology

Rubrik pops 20% in NYSE debut after pricing IPO above range

Published

on

By

Rubrik pops 20% in NYSE debut after pricing IPO above range

Bipul Sinha, CEO, Chairman & Co-Founder of Rubrik Inc., the Microsoft backed cybersecurity software startup, rings the opening bell during his company’s IPO at the New York Stock Exchange (NYSE) in New York City, U.S., April 25, 2024. 

Brendan Mcdermid | Reuters

Data management software maker Rubrik jumped in its New York Stock Exchange debut on Thursday, the latest sign that public market investors are showing an appetite for tech IPOs.The stock opened at $38.60 per share, after the Microsoft-backed company priced its IPO at $32 a share on Wednesday, above its expected range of $28 to 31 per share.

In selling 23.5 million shares, it raised $752 million, leaving it with a valuation of $5.6 billion. Rubrik shares are trading under the ticker “RBRK.”

Many technology companies appeared on public markets in the 2010s as central banks kept interest rates low. Worries about a weakening economy starting in late 2021 led investors to become less interested in unprofitable companies. Since then, few young technology companies have been willing to try going public. But that could be changing. Reddit and Astera Labs, which sells data center connectivity chips, went public in March.

Rubrik, founded a decade ago, reported a $354 million net loss in the latest fiscal year, compared to a $278 million loss in the year prior. The company now generates 91% of its revenue from subscriptions, up from 59% two years ago. 

Microsoft invested in the company in 2021. Rubrik’s co-founder and CEO, Bipul Sinha, has 8% control. Lightspeed Venture Partners, where Sinha used to be a startup investor, has 25% of the voting power.

Sinha said Rubrik isn’t able to control market conditions but was able to prepare itself to go public.

“When we see the market is receptive and we were ready, we go,” he said in an interview.

A company will decide on the timing for its IPO six to eight weeks ahead, relying partly on input from bankers, said Ravi Mhatre, managing director at Lightspeed Venture Partners, which was the sole investor in Rubrik’s first round of venture capital.

Input from investors was also critical.

“Bipul spent a lot of time with public market investors both in 2023 and then in 2024,” said Mhatre, whose firm invested some $362 million in Rubrik.

From those conversations, Sinha has gotten a sense of what investors would be interested in.

“Folks are looking for strong companies to go public, companies that have the potential to be a durable business, a moat in the marketplace, has something to unique to offer in the marketplace and clearly winning in the marketplace,” Sinha said. “Staying public is the key, not going public.”

This story is developing. Please check back for updates.

Continue Reading

Technology

Stripe co-founder says high interest rates flushed out Silicon Valley’s ‘wackiest’ ideas

Published

on

By

Stripe co-founder says high interest rates flushed out Silicon Valley's 'wackiest' ideas

John Collison, president and co-founder of Stripe.

Christophe Morin | IP3 | Getty Images

Rising interest rates crushed technology valuations and had a chilling effect on Silicon Valley. Stripe’s co-founder says it was needed.

“Broadly speaking, the effects of higher rates have been quite good,” John Collison, president of the online payments company, told CNBC in an interview at the company’s annual conference Wednesday. “The period where money was free was not a healthy time in Silicon Valley.”

Collison founded Stripe with his brother Patrick in 2010. The company took off, becoming a startup darling and racing to a valuation of $95 billion in 2021, making it one of the world’s most valuable venture-backed businesses, behind Elon Musk’s SpaceX.

Stripe had to take a major haircut along with the rest of the industry as soaring inflation and rising interest rates, starting in 2022, pushed investors out of the riskiest assets, lifted borrowing costs and forced startups to tighten their belts.

Stripe slashed its valuation to $50 billion in a 2023 financing round. Its recent employee tender offer valued the company at closer to $65 billion, The Wall Street Journal reported.

“Valuations are a product of interest rates,” Collison said. Still, he said, “Stripe’s business is the healthiest it’s ever been.” Regarding the drop in valuation, he added, “We’re not losing sleep over it.”

Stripe processed $1 trillion last year, up 25% from 2023, the company said in its annual letter.

While many tech companies took a hit in 2022 and 2023, Collison said the rising interest rate environment succeeded in flushing out the “wackiest” startup ideas, leaving the best ones to get funded.

He pointed to an “overfunding” of marginally good ideas, and “zombie companies” taking too long to go bust.

“That’s not good for dynamic capital allocation in the broader economy,” Collison said. “You want people to be working on the most valuable ideas, and not on the marginal ideas.

Following an extended stretch of rock-bottom borrowing costs, the Federal Reserve started lifting rates in 2022, and hiked its benchmark rate last year to the highest since 2001. Rates have held steady since, and recent statements by Fed Chair Jerome Powell and other policymakers have cemented the notion that cuts aren’t coming in the next several months. 

Federal Reserve Bank Chair Jerome Powell speaks during a news conference at the bank’s William McChesney Martin building on March 20, 2024 in Washington, DC.

Chip Somodevilla | Getty Images News | Getty Images

Collison said there’s more pain coming.

The “point of high rates is that they should hurt, and they haven’t hurt enough yet,” he said. “We should just assume that the hurt takes a bit longer to arrive.”

One part of the tech market that’s powering through the higher rate environment is artificial intelligence, where there “seems to be a new AI funding round every week,” Collison said.

This week, Perplexity announced a $63 million funding round that pushed its valuation above $1 billion. SoftBank and Jeff Bezos are among its backers.

Stripe is benefiting in its own way from the euphoria. OpenAI, Anthropic and Hugging Face are among the AI startups using the company’s payment processing technology.

“I can’t remember a time in Silicon Valley where it has felt like there was as much interest in tech advances taking place,” Collison said of the AI boom. “It’s just a fun time to be in tech, broadly.”

As for Stripe’s future, an eventual IPO has been a source of speculation for years given the company’s lofty valuation and its roster of high-profile backers thirsting for a return on their investment. Collison said Stripe is in “no rush,” and that executives are focused on providing liquidity to employees through secondary share sales.

“We have no timeline that we’re announcing on being a public company,” he said. “The thing that we were quite focused on is making sure that there is good liquidity for employees.”

WATCH: Nasdaq CEO on Q1 results and IPO landscape

Nasdaq CEO Adena Friedman on Q1 results, 2024 IPO landscape and AI impact

Continue Reading

Trending